Back
ESC Premium Access

Opening remarks - Protecting patients through responsible use of NOACs... The right dose for the right patient for stroke prevention.

logo

Session: Protecting patients through responsible use of novel oral anticoagulants (NOACs)... The right dose for the right patient for stroke prevention
Topic: Atrial fibrillation (AF)
Speaker: Professor R. Mehran (New York, US)
Sponsored by Bayer AG
Event: ESC Congress 2017

Congress Presentation

0

About the speaker

Professor Roxana Mehran

Icahn School of Medicine at Mount Sinai, New York (United States of America)
35 presentations
9 followers

4 more presentations in this session

New insights on treating patients with atrial fibrillation (AF) who are undergoing percutaneous coronary intervention (PCI) stenting.

Speaker: Professor K. Fox (Edinburgh, GB)

Access
Slides
Video
0
Thumbnail

Special considerations in the management of patients with AF undergoing ablation or cardioversion.

Speaker: Professor S. Hohnloser (Frankfurt, DE)

Access
Slides
Video
0
Thumbnail

How can we appropriately treat multimorbid patients with AF?

Speaker: Doctor C. Ruff (Boston, US)

Access
Slides
Video
0
Thumbnail

Closing remarks - Protecting patients through responsible use of NOACs... The right dose for the right patient for stroke prevention.

Speaker: Doctor R. Cappato (Milan, IT)

Access
Slides
Video
0
Thumbnail

Access the full session

Protecting patients through responsible use of novel oral anticoagulants (NOACs)... The right dose for the right patient for stroke prevention

Speakers: Professor R. Mehran, Professor K. Fox, Professor S. Hohnloser, Doctor C. Ruff, Doctor R. Cappato
Access
0
Thumbnail

About the event

Image

ESC Congress 2017

26 August - 30 August 2017

Sessions Presentations

Congress
logo Image

ESC 365 is supported by

logo Novo Nordisk